MedPath
FDA Product

LETROZOLE

Product approved by U.S. Food and Drug Administration (US)

Basic Information

LETROZOLE

50268-476

Regulatory Information

50268-476

ANDA200161

C73584

January 9, 2024

USA

Letrozole Tablets, USP Rx only These highlights do not include all the information needed to use LETROZOLE TABLETS safely and effectively. See full prescribing information for LETROZOLE TABLETS. Initial U.S. Approval: 1997

HUMAN PRESCRIPTION DRUG LABEL

3

Company Information

AvPAK

832926666

Active Ingredients

LACTOSE MONOHYDRATE

Code: EWQ57Q8I5X

Class Code: IACT

MAGNESIUM STEARATE

Code: 70097M6I30

Class Code: IACT

HYPROMELLOSE 2910 (6 MPA.S)

Code: 0WZ8WG20P6

Class Code: IACT

POLYETHYLENE GLYCOL 8000

Code: Q662QK8M3B

Class Code: IACT

MICROCRYSTALLINE CELLULOSE

Code: OP1R32D61U

Class Code: IACT

SILICON DIOXIDE

Code: ETJ7Z6XBU4

Class Code: IACT

STARCH, CORN

Code: O8232NY3SJ

Class Code: IACT

TITANIUM DIOXIDE

Code: 15FIX9V2JP

Class Code: IACT

TALC

Code: 7SEV7J4R1U

Class Code: IACT

SODIUM STARCH GLYCOLATE TYPE A POTATO

Code: 5856J3G2A2

Class Code: IACT

FERRIC OXIDE YELLOW

Code: EX438O2MRT

Class Code: IACT

LETROZOLE

Quantity: 2.5 mg in 1 1

Code: 7LKK855W8I

Class Code: ACTIB

Active Moieties

LETROZOLE

Code: 7LKK855W8I

© Copyright 2025. All Rights Reserved by MedPath